Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty

Luís Mata, Xavier Bosch, Paul Robert David, +3

Journal of the American College of Cardiology

Percutaneous Coronary InterventionVascular ImageCardiovascular DiseaseCoronary Artery DiseaseSurgery +7

Platelet Membrane Receptor Glycoprotein IIb/IIIa Antagonism in Unstable Angina

Pierre Roux, Simon Kouz, Louis Roy, +12

Circulation

Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.

Hans J. Rapold, H. KUEMMERLI, M B Weiss, +2

Circulation

ThrombosisHeart FailureCardiovascular DiseaseThrombolytic TherapyStroke +13

Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)

Jef Arnout, Maarten L. Simoons, David de Bono, +3

Journal of the American College of Cardiology

ThrombosisInfarct-related Coronary ArteryCardiovascular DiseaseCoronary Artery DiseaseAcute Myocardial Infarction +5

Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. Correlation with concomitant heparin, coronary artery patency, and recurrent ischemia. The European Cooperative Study Group.

Hans J. Rapold, David de Bono, Alfred Arnold, +4

Circulation

Restenosis and its determinants in first and repeat coronary angioplasty

Hans J. Rapold, P David, Pere Guiteras Val, +3

European Heart Journal

Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model.

D Collen, M Dewerchin, Hans J. Rapold, +2

Circulation

Immunocytochemical TechniqueFemoral Vein SegmentImmunologyImmunotherapyThrombosis +17

An Exploratory Trial of Two Dosages of a Novel Synthetic Thrombin Inhibitor (Napsagatran, Ro 46-6240) Compared with Unfractionated Heparin for Treatment of Proximal Deep-vein Thrombosis

Henri Bounameaux, H Ehringer, Johan Hulting, +3

Thrombosis and Haemostasis

PharmacotherapyHeparin Control GroupThrombosisVenous ThrombosisAdvent Trial +20

Randomized, placebo-controlled study of Lamifiban with thrombolytic therapy for the treatment of acute myocardial infarction: Rationale and design for the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) study

David J. Moliterno, Robert A. Harrington, Robert M. Califf, +2

Journal of Thrombosis and Thrombolysis

ThrombosisReperfusion GainCardiovascular DiseaseBlood PlateletMedicine +8

Fibrin formation and platelet activation in patients with myocardial infarction and normal coronary arteries

Hans J. Rapold, André Haeberli, H. KUEMMERLI, +3

European Heart Journal